The Microbiome and Mucosal Immunity in Cervical Cancer Disparities
宫颈癌差异中的微生物组和粘膜免疫
基本信息
- 批准号:10347718
- 负责人:
- 金额:$ 55.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-25 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAffectAfricanAfrican AmericanAmericanAnaerobic BacteriaArginineBacteriaBiological MarkersBiologyButyratesCellsCervicalCervical Intraepithelial NeoplasiaCervix NeoplasmsCessation of lifeClinicCohort StudiesColposcopyCommunitiesCoupledDataDatabasesDeveloping CountriesDiseaseDisease ProgressionDisease remissionDisseminated Malignant NeoplasmEnvironmentEpithelialEuropeanFRAP1 geneFemaleFemale genitaliaFlow CytometryFunctional disorderGardnerella vaginalisGene ExpressionGene ProteinsGenerationsGenitalGenitaliaHPV-High RiskHigh PrevalenceHuman PapillomavirusImmuneImmune checkpoint inhibitorImmune responseImmunityImmunologyImmunosuppressionIn VitroInflammationInflammatoryInfrastructureInterleukin-6InterventionLactobacillusLeadLimited StageLinkMalignant NeoplasmsMalignant neoplasm of cervix uteriMeasurementMediator of activation proteinMetagenomicsMobiluncusMolecularMolecular ProfilingMucosal ImmunityMucous MembraneMusOutcomePathogenesisPathologyPathway interactionsPersonsPhenotypePopulationPreventive vaccinePrevotellaProcessPropionatesProspective StudiesRegulatory T-LymphocyteRoleSamplingSocioeconomic StatusSystems BiologyT-LymphocyteTNF geneTechniquesThe Cancer Genome AtlasTimeTissuesTreatment outcomeTryptophanTryptophan 2,3 DioxygenaseUgandaUnited StatesVaccinesVaginaWomanbasecancer health disparitycancer riskcarcinogenicitycost effectivedysbiosisexperiencehealth disparityhigh riskimprovedin vivometabolomicsmetaproteomicsmicrobialmicrobiomemicrobiome researchmicroorganismmortalitymouse modelnovel therapeutic interventionpredictive markerprospectiverecruitreproductive tractsingle-cell RNA sequencingsurvival disparitytumor progressiontumor-immune system interactionsvaccine accessvaginal microbiomevaginal mucosa
项目摘要
The microbiome and mucosal immunity in cervical cancer disparities
African American women living in the United States continue to experience an undue higher burden of
cervical cancer and a >2 times higher mortality rate than European American women. This survival disparity
persists after accounting for socioeconomic status and disease stage. The presence of high-risk human
papillomavirus (HPV) is the major cause of cervical cancer and cervical intraepithelial neoplasia. Prophylactic
vaccines are available against the most carcinogenic types and are highly effective, but disparities persist and
the number of people receiving the vaccine remains suboptimal especially for African American women, and the
vaccine is ineffective for the 40% of female US population already infected with genital HPV. Treatment options
for advanced stages are limited, and metastatic cancer is incurable. New therapeutic approaches are therefore
needed but the mucosal mechanisms contributing to disease pathogenesis in African American women are not
well understood. Therefore, identifying mucosal processes and/or mediators which modify HPV persistence vs
clearance and progression vs remission of cervical neoplasia could lead to new or improved treatments and
better CC outcomes for women.
In this proposal we will investigate the contribution of the microbiome and mucosal immunity in the female
genital tract to health disparities in cervical cancer in African American women. This is built upon considerable
data from our lab and others that show that African American women have higher proportion of vaginal microbial
dysbiosis; that vaginal microbial dysbiosis is linked to pro-inflammatory and cancer pathways in cervical mucosa;
that these bacteria produce metabolites that are linked to an immunosuppressive phenotype; that dysbiotic
bacteria can induce cancer pathways in vitro; and cervical cancer tissue gene expression data from African
American women show increased activation inflammatory pathways compared to European American women.
In this concept we will utilize state-of-the-art systems biology techniques, including metagenomics,
metaproteomics, metabolomics, single cell RNA sequencing and flow cytometry to study vaginal mucosal biology
in prospective studies of African American women, coupled with functional studies in PV-associated cervical
cancer mouse models, to better understand these relationships.
微生物组和粘膜免疫在宫颈癌中的差异
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stefanie Avril其他文献
Stefanie Avril的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stefanie Avril', 18)}}的其他基金
The Microbiome and Mucosal Immunity in Cervical Cancer Disparities
宫颈癌差异中的微生物组和粘膜免疫
- 批准号:
10613512 - 财政年份:2022
- 资助金额:
$ 55.95万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 55.95万 - 项目类别:
Research Grant














{{item.name}}会员




